Prostate Cancer News and Research

Latest Prostate Cancer News and Research

CD5 knockout using CRISPR boosts CAR T cell therapy efficacy

The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by using CRISPR-Cas9 technology to knock out the gene for CD5, a protein found on the surface of T cells, according to a preclinical study from investigators at the University of Pennsylvania's Perelman School of Medicine and Abramson Cancer Center.

19 Jul 2024

Diverse genetic data illuminates health disparities across populations

The majority of genetic studies focus on people of European descent, which limits the understanding of how genes influence health in other populations.

18 Jul 2024

Harnessing ctDNA measurements for response assessment in metastatic castration resistant prostate cancer

A new editorial paper was published in Oncotarget's Volume 15 on July 2, 2024, entitled, "Using early on-treatment circulating tumor DNA measurements as response assessment in metastatic castration resistant prostate cancer."

18 Jul 2024

Out-of-pocket costs from diagnostic testing after prostate cancer screening are common and rising

Prostate-specific antigen (PSA) screening aims to identify men who may harbor potentially lethal prostate cancer, and those with high PSA results often require more extensive (and expensive) diagnostic testing to establish a diagnosis.

15 Jul 2024

Neighborhood disadvantage linked to higher expression of stress-related genes in prostate tumors

Those living in disadvantaged neighborhoods have significantly higher activity of stress-related genes, new research suggests, which could contribute to higher rates of aggressive prostate cancer in African American men.

12 Jul 2024

Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

A recent European Urology Oncology study assessed the mortality risks, based on the Gleason score and clinical parameters, in patients with prostate cancer.

11 Jul 2024

Gut bacteria-metabolized equol shows promise in cancer prevention

Researchers reviewed how soy isoflavones are metabolized by gut bacteria into equol, exploring its role in cancer prevention and treatment. They examined the molecular mechanisms and gut microbiota involved to understand equol's anti-tumor effects.

11 Jul 2024

Study highlights hidden aggressiveness in Gleason Grade Group 1 prostate cancer

New research highlights the challenge of balancing the risks of overdiagnosing and underdiagnosing prostate cancer early enough to intervene and minimize risk of death.

9 Jul 2024

What is the difference in risk of early prostate cancer death between men at higher vs lower genetic risk?

The risk of early prostate cancer death among men with higher versus lower genetic risk.

9 Jul 2024

Research reveals immune suppression link between cancer and pregnancy

To understand why some cancers successfully circumvent the immune system to grow unchecked, researchers turned to pregnancy.

8 Jul 2024

Machine learning identifies cancer-driving mutations at CTCF binding sites

Researchers developed a machine learning tool, CTCF-INSITE, to identify mutational hotspots at persistent CTCF binding sites across various cancers, highlighting their role in genomic structure disruption and cancer progression.

7 Jul 2024

RNA splicing modulation as a precision approach for neuroendocrine cancer treatment

Neuroendocrine tumors, including small cell lung cancer and neuroendocrine prostate cancer, are very aggressive with high chances of spreading.

2 Jul 2024

Pharmacogenomics: A pathway to personalized treatment in prostate cancer

Prostate cancer (PC) stands as the second leading cause of death among American men, with about 1 in 8 men diagnosed during their lifetime.

2 Jul 2024

Study alerts transwomen to interpret standard prostate cancer screening guidelines with caution

UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.

28 Jun 2024

AI-powered lesion delineation in prostate cancer PET/CT imaging

A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, "Deep learning-assisted lesion segmentation in PET/CT imaging: A feasibility study for salvage radiation therapy in prostate cancer."

28 Jun 2024

Current screening guidelines could miss prostate cancer in transgender women receiving estrogen

Transgender women are still at risk for prostate cancer. A new study led by Cedars-Sinai Cancer investigators, published in the peer-reviewed Journal of the American Medical Association, concludes that current screening guidelines could miss early-stage prostate cancer in transgender women on hormone therapy.

26 Jun 2024

Research finds increased cancer risk in diabetic adults aged 40-54 years

Diabetes significantly increases the risk of cancer, particularly in people aged 40-54 years, new research shows.

26 Jun 2024

Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasis

Weill Cornell Medicine received a $1.5 million grant from the U.S. Department of Defense Prostate Cancer Research Program to develop new approaches for predicting the spread of cancer cells to the bone in men with prostate cancer, using tumor samples taken at early stages of the disease.

25 Jun 2024

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

The U.S. Food and Drug Administration (FDA) has expanded orphan drug designation for SurVaxM, a brain cancer immunotherapy born in the labs of Roswell Park Comprehensive Cancer Center.

25 Jun 2024

UCF researcher further explores nanotech to improve cancer and disease detection

Early discovery of debilitating diseases such as cancer or dementia is critical in determining treatment and saving lives.

21 Jun 2024

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

CD5 knockout using CRISPR boosts CAR T cell therapy efficacy

Diverse genetic data illuminates health disparities across populations

Harnessing ctDNA measurements for response assessment in metastatic castration resistant prostate cancer

Out-of-pocket costs from diagnostic testing after prostate cancer screening are common and rising

Neighborhood disadvantage linked to higher expression of stress-related genes in prostate tumors

Researchers identify two risk factors that indicate higher risk of aggressive prostate cancer

Gut bacteria-metabolized equol shows promise in cancer prevention

Study highlights hidden aggressiveness in Gleason Grade Group 1 prostate cancer

What is the difference in risk of early prostate cancer death between men at higher vs lower genetic risk?

Research reveals immune suppression link between cancer and pregnancy

Machine learning identifies cancer-driving mutations at CTCF binding sites

RNA splicing modulation as a precision approach for neuroendocrine cancer treatment

Pharmacogenomics: A pathway to personalized treatment in prostate cancer

Study alerts transwomen to interpret standard prostate cancer screening guidelines with caution

AI-powered lesion delineation in prostate cancer PET/CT imaging

Current screening guidelines could miss prostate cancer in transgender women receiving estrogen

Research finds increased cancer risk in diabetic adults aged 40-54 years

Weill Cornell Medicine receives $1.5M grant to predict prostate cancer bone metastasis

FDA expands orphan drug designation for Roswell Park's brain cancer immunotherapy

UCF researcher further explores nanotech to improve cancer and disease detection

What to know about prostate cancer eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Prostate Cancer News and Research

Latest Prostate Cancer News and Research

What to know about prostate cancer eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in